The Atrial Fibrillation Market was worth USD 3.43 billion in the year 2013 and is expected to reach approximately USD 8.96 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 11.25% during the forecast period. The worldwide atrial fibrillation market is anticipated to encounter a critical development over the figure time frame.
The worldwide atrial fibrillation market is segmented into Surgical, EP Ablation and Diagnostic on the basis of applications. EP Ablation section of the application segment is expected to demonstrate highest market share over the forecast period as it is generally utilized as surgical devices for the treatment of heart arrhythmias. Moreover, EP Ablation is mostly preferred when anticoagulant drugs and different meds cannot be regulated or endured by the patient. Hence, this section is expected to show significant growth of the atrial fibrillation market in the upcoming years. The worldwide atrial fibrillation market is segmented into Electrophysiology Labs, Hospitals and Ambulatory Surgical Center on the basis of end users. Hospital section of the end user segments is expected to demonstrate highest market share over the forecast period owing to the increased applications of catheter ablation for curing atrial fibrillation.
The report Atrial Fibrillation Market renders a wide-ranging analysis of the said market in terms of product, regional, application and end user segmentation. The report comprises of the present market size of this industry. Also, the potential outlooks and current market summary of this segment has been thoroughly analyzed in this report. Moreover, chief market players of the Atrial Fibrillation are studied on various factors like product portfolio, company profile, sales analysis, revenue generation through the forecast period.